129 related articles for article (PubMed ID: 18571496)
1. Modulation of ephrinB2 leads to increased angiogenesis in ischemic myocardium and endothelial cell proliferation.
Månsson-Broberg A; Siddiqui AJ; Genander M; Grinnemo KH; Hao X; Andersson AB; Wärdell E; Sylvén C; Corbascio M
Biochem Biophys Res Commun; 2008 Aug; 373(3):355-9. PubMed ID: 18571496
[TBL] [Abstract][Full Text] [Related]
2. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
3. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
4. Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31.
Korff T; Dandekar G; Pfaff D; Füller T; Goettsch W; Morawietz H; Schaffner F; Augustin HG
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):468-74. PubMed ID: 16357318
[TBL] [Abstract][Full Text] [Related]
5. Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature.
Maekawa H; Oike Y; Kanda S; Ito Y; Yamada Y; Kurihara H; Nagai R; Suda T
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2008-14. PubMed ID: 14500293
[TBL] [Abstract][Full Text] [Related]
6. Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck.
Kimura M; Kato Y; Sano D; Fujita K; Sakakibara A; Kondo N; Mikami Y; Tsukuda M
Int J Oncol; 2009 Feb; 34(2):321-7. PubMed ID: 19148465
[TBL] [Abstract][Full Text] [Related]
7. Human leukocytes express ephrinB2 which activates microvascular endothelial cells.
Zamora DO; Babra B; Pan Y; Planck SR; Rosenbaum JT
Cell Immunol; 2006 Aug; 242(2):99-109. PubMed ID: 17123494
[TBL] [Abstract][Full Text] [Related]
8. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
Héroult M; Schaffner F; Pfaff D; Prahst C; Kirmse R; Kutschera S; Riedel M; Ludwig T; Vajkoczy P; Graeser R; Augustin HG
Mol Cancer Res; 2010 Oct; 8(10):1297-309. PubMed ID: 21047731
[TBL] [Abstract][Full Text] [Related]
9. Stromal cells modulate ephrinB2 expression and transmigration of hematopoietic cells.
Okubo T; Yanai N; Obinata M
Exp Hematol; 2006 Mar; 34(3):330-8. PubMed ID: 16543067
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF
Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906
[TBL] [Abstract][Full Text] [Related]
12. Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization.
Hayashi S; Asahara T; Masuda H; Isner JM; Losordo DW
Circulation; 2005 May; 111(17):2210-8. PubMed ID: 15851594
[TBL] [Abstract][Full Text] [Related]
13. Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells.
Zheng LC; Wang XQ; Lu K; Deng XL; Zhang CW; Luo H; Xu XD; Chen XM; Yan L; Wang YQ; Shi SL
Oncotarget; 2017 Jun; 8(25):41348-41363. PubMed ID: 28489586
[TBL] [Abstract][Full Text] [Related]
14. EphrinB2/EphB4 Signaling Regulates DPSCs to Induce Sprouting Angiogenesis of Endothelial Cells.
Gong T; Xu J; Heng B; Qiu S; Yi B; Han Y; Lo ECM; Zhang C
J Dent Res; 2019 Jul; 98(7):803-812. PubMed ID: 31017515
[TBL] [Abstract][Full Text] [Related]
15. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
[TBL] [Abstract][Full Text] [Related]
16. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
Erber R; Eichelsbacher U; Powajbo V; Korn T; Djonov V; Lin J; Hammes HP; Grobholz R; Ullrich A; Vajkoczy P
EMBO J; 2006 Feb; 25(3):628-41. PubMed ID: 16424904
[TBL] [Abstract][Full Text] [Related]
17. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.
Shin D; Garcia-Cardena G; Hayashi S; Gerety S; Asahara T; Stavrakis G; Isner J; Folkman J; Gimbrone MA; Anderson DJ
Dev Biol; 2001 Feb; 230(2):139-50. PubMed ID: 11161568
[TBL] [Abstract][Full Text] [Related]
18. Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.
Ozgür E; Heidenreich A; Dagtekin O; Engelmann U; Bloch W
Urol Oncol; 2011; 29(1):78-84. PubMed ID: 19272799
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of endothelial ephrinB2 expression by laminar shear stress.
Goettsch W; Augustin HG; Morawietz H
Endothelium; 2004; 11(5-6):259-65. PubMed ID: 15763946
[TBL] [Abstract][Full Text] [Related]
20. EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease.
Yang D; Jin C; Ma H; Huang M; Shi GP; Wang J; Xiang M
Angiogenesis; 2016 Jul; 19(3):297-309. PubMed ID: 27216867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
